Identifying Synergistic Mechanisms of Multiple Ingredients in Shuangbai Tablets against Proteinuria by Virtual Screening and a Network Pharmacology Approach

Abstract

Shuangbai Tablets (SBT), a traditional herbal mixture, has shown substantial clinical efficacy. However, a systematic mechanism of its active ingredients and pharmacological mechanisms of action against proteinuria continues being lacking. A network pharmacology approach was effectual in discovering the relationship of multiple ingredients and targets of the herbal mixture. This study aimed to identify key targets, major active ingredients, and pathways of SBT against proteinuria by network pharmacology approach combined with thin layer chromatography (TLC). Human phenotype (HP) disease analysis, gene ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, and molecular docking were used in this study. To this end, a total of 48 candidate targets of 118 active ingredients of SBT were identified. Network analysis showed PTGS2, ESR1, and NOS2 to be the three key targets, and beta-sitosterol, quercetin, and berberine were the three major active ingredients; among them one of the major active ingredients, quercetin, was discriminated by TLC. These results of the functional enrichment analysis indicated that the most relevant disease including these 48 candidate proteins is proteinuria, SBT treated proteinuria by sympathetically regulating multiple biological pathways, such as the HIF-1, RAS, AGE-RAGE, and VEGF signaling pathways. Additionally, molecular docking validation suggested that major active ingredients of SBT were capable of binding to HIF-1A and VEGFA of the main pathways. Consequently, key targets, major active ingredients, and pathways based on data analysis of SBT against proteinuria were systematically identified confirming its utility and providing a new drug against proteinuria.

Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease

“…Virtual screening and network pharmacology are effective ways to find the relationship between multiple components and targets of TCM [64,65]. In the present study, we identified the systemic mechanisms of GXV in the treatment of CAD by these approaches, which provides a new strategy to study the potential active components and targets of TCM [66,67].…”

Investigating the Molecular Mechanism of Quercetin Protecting against Podocyte Injury to Attenuate Diabetic Nephropathy through Network Pharmacology, MicroarrayData Analysis, and Molecular Docking

“…KEGG consists of artificially annotated metabolic pathways and defines the complex interrelationship between genes and metabolites [ 33 ]. R project software has been widely used in network pharmacology studies for screening of DEGs, enrichment, and annotation analysis [ 37 , 44 ].…”

Exploration of the Potential Mechanism of Tao Hong Si Wu Decoction for the Treatment of Breast Cancer Based on Network Pharmacology and In Vitro Experimental Verification

“…Through network pharmacology, data on ingredients, diseases, and their related targets are often gathered through existing online databases, and visualization software is then used to systematically analyze TCMs by constructing an "ingredienttarget-pathway" network, so as to define the drug intervention and the treatment effects on different diseases (9). The systematic nature of network pharmacology is consistent with the holistic view and syndrome differentiation theory of TCM has been widely applied to the study of TCM to generate new research data, methods and results (10)(11)(12). Based on this approach, we used network databases to construct an "ingredient-target" network, a PPI network for enrichment analysis.…”